Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed

Summary by PR Newswire
/PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune...

18 Articles

Bennington BannerBennington Banner
+17 Reposted by 17 other sources
Center

Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed

BETHESDA, Md., Oct. 24, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that its acquisition of Advent BioServices Ltd. ("Advent") has closed. As a…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources are Center
63% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Friday, October 24, 2025.
Sources are mostly out of (0)

Similar News Topics

Bethesda, Maryland icon

Bethesda, Maryland

News
For You
SearchBlindspotLocal